• Brain Tumor Clinical Trials

    Our research and clinical trials have made us a leader in improving survival rates for hard-to-treat pediatric brain tumors like medulloblastoma and atypical teratoid rhabdoid tumor (ATRT). We also were the first pediatric hospital to install a mobile “intraoperative MRI,” which allows surgeons to obtain images while the patient is still under anesthesia and to perform further procedures as needed.

    Search our current clinical trials below. To learn more, email us at clinicaltrials@danafarberbostonchildrens.org or read our clinical trial FAQ for answers to general questions.

    Featured Trials

    Dr. Mark Kieran
    Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

    The primary objective of this study is to estimate the overall survival of children and young adults with Diffuse Intrinsic Pontine Glioma (DIPG) treated with a molecularly- based treatment strategy, compared to historic controls and evaluate the safety and feasibility of performing biopsy and obtaining tissue useful for histologic diagnosis, immunohistochemistry and DNA analysis in patients with newly diagnosed DIPG. PI: Mark W. Kieran, MD, PhD
    Please note: This trial completed accrual in November 2015 and is now closed. More information will be available soon.


    Search Trials by Condition

    Search for pediatric brain tumor clinical trials by condition using the links below, or download a summary of all current trials at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

  • Brain Tumor Consultations and Second Opinions

    Call 1-855-320-2093 to schedule a consultation, referral, or second opinion.
  • Ranked #1 for Cancer Care

    US NewsRated the top pediatric cancer center by U.S. News & World Report
  • Clinical Trial FAQs

    Get answers to common questions about clinical trials: What are clinical trials? Is a clinical trial the right choice for my child?